Tag:
Contract Pharmacal
Latest Headlines
Latest Headlines
Newly posted warnings cite repeat violations
Pointed references to repeat violations characterize three GMP warning letters posted by the FDA this week. Repeat offenses are a sore spot with the regulator and increasingly cited in its references
